Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2005. Start Trial.
Date Value
September 30, 2026 90.48%
June 30, 2026 90.37%
March 31, 2026 90.16%
December 31, 2025 89.15%
September 30, 2025 89.21%
June 30, 2025 87.76%
March 31, 2025 87.72%
December 31, 2024 87.43%
September 30, 2024 86.56%
June 30, 2024 79.54%
March 31, 2024 86.39%
December 31, 2023 88.48%
September 30, 2023 82.53%
June 30, 2023 82.57%
March 31, 2023 85.77%
December 31, 2022 86.98%
September 30, 2022 80.65%
June 30, 2022 82.78%
March 31, 2022 84.96%
December 31, 2021 81.83%
September 30, 2021 81.30%
June 30, 2021 77.19%
March 31, 2021 81.19%
December 31, 2020 31.80%
September 30, 2020 32.26%
Date Value
June 30, 2020 33.52%
March 31, 2020 28.83%
December 31, 2019 37.67%
September 30, 2019 38.30%
June 30, 2019 16.83%
March 31, 2019 57.09%
December 31, 2018 49.52%
September 30, 2018 56.10%
June 30, 2018 56.09%
March 31, 2018 51.60%
December 31, 2017 32.23%
September 30, 2017 54.77%
June 30, 2017 54.64%
March 31, 2017 47.19%
December 31, 2016 43.89%
September 30, 2016 47.80%
June 30, 2016 43.97%
March 31, 2016 43.95%
December 31, 2015 46.03%
September 30, 2015 45.42%
June 30, 2015 43.83%
March 31, 2015 44.50%
December 31, 2014 43.85%
September 30, 2014 45.64%
June 30, 2014 47.13%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
MBody AI Ltd. --
Zepp Health Corp. 37.35%
ACI Worldwide, Inc. 36.62%
ASML Holding NV 57.45%
Autoscope Technologies Corp. 94.18%